Atorvastatin as a Potential Antimalarial Drug: In Vitro Synergy in Combinational Therapy with Dihydroartemisinin
- 1 February 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (2), 966-967
- https://doi.org/10.1128/aac.01006-09
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Atorvastatin Is a Promising Partner for Antimalarial Drugs in Treatment of Plasmodium falciparum MalariaAntimicrobial Agents and Chemotherapy, 2009
- Plasmodium falciparumNa+/H+Exchanger 1 Transporter Is Involved in Reduced Susceptibility to QuinineAntimicrobial Agents and Chemotherapy, 2009
- Statins as Potential Antimalarial Drugs: Low Relative Potency and Lack of Synergy with Conventional Antimalarial DrugsAntimicrobial Agents and Chemotherapy, 2009
- Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous DeploymentPLOS ONE, 2009
- Compactness Determines the Success of Cube and Octahedron Self-AssemblyPLOS ONE, 2009
- Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern CambodiaMalaria Journal, 2009
- Statins Alone Are Ineffective in Cerebral Malaria but Potentiate ArtesunateAntimicrobial Agents and Chemotherapy, 2008
- Molecular Surveillance for Multidrug-ResistantPlasmodium falciparum, CambodiaEmerging Infectious Diseases, 2008
- Atorvastatin Is 10-Fold More Active In Vitro than Other Statins against Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2007
- Tolerance and Pharmacokinetics of Single‐Dose Atorvastatin, a Potent Inhibitor of HMG‐CoA Reductase, in Healthy SubjectsThe Journal of Clinical Pharmacology, 1996